AAAAAA

   
Results: 1-7 |
Results: 7
In vitro preclinical models for a rational design of chemotherapy combinations in human tumors
Authors: Zoli, W Ricotti, L Tesei, A Barzanti, F Amadori, D
Citation: W. Zoli et al., In vitro preclinical models for a rational design of chemotherapy combinations in human tumors, CR R ONC H, 37(1), 2001, pp. 69-82
Lanreotide-induced modulation of 5-fluorouracil or mitomycin C cytotoxicity in human colon cancer cell lines: a preclinical study
Authors: Tesei, A Ricotti, L De Paola, F Casini-Raggi, C Barzanti, F Frassineti, GL Zoli, W
Citation: A. Tesei et al., Lanreotide-induced modulation of 5-fluorouracil or mitomycin C cytotoxicity in human colon cancer cell lines: a preclinical study, J CHEMOTHER, 12(5), 2000, pp. 421-430
Comparison between different cell kinetic variables in human breast cancer
Authors: Barzanti, F Dal Susino, M Volpi, A Amadori, D Riccobon, A Scarpi, E Medri, L Bernardi, L Naldi, S Aldi, M Gaudio, M Zoli, W
Citation: F. Barzanti et al., Comparison between different cell kinetic variables in human breast cancer, CELL PROLIF, 33(2), 2000, pp. 75-89
Combined 4-hydroxy-ifosfamide and vinorelbine treatment in established andprimary human breast cell cultures
Authors: Ricotti, L Barzanti, F Tesei, A Amadori, D Gasperi-Campani, A Frassineti, GL Zoli, W
Citation: L. Ricotti et al., Combined 4-hydroxy-ifosfamide and vinorelbine treatment in established andprimary human breast cell cultures, ANN ONCOL, 11(5), 2000, pp. 587-594
Correlation between p53 gene mutations and p53 protein accumulation evaluated by different methodologies
Authors: Calistri, D Barzanti, F Dal Susino, M Fedriga, R Saragoni, L Bernardi, L Ricotti, L Zoli, W
Citation: D. Calistri et al., Correlation between p53 gene mutations and p53 protein accumulation evaluated by different methodologies, J BIOL REG, 14(2), 2000, pp. 120-127
Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines
Authors: Zoli, W Ricotti, L Barzanti, F Dal Susino, M Frassineti, GL Milandri, C Giunchi, DC Amadori, D
Citation: W. Zoli et al., Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines, INT J CANC, 80(3), 1999, pp. 413-416
Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer
Authors: Zoli, W Ricotti, L Dal Susino, N Barzanti, F Frassineti, GL Folli, S Tesei, A Bacci, F Amadori, D
Citation: W. Zoli et al., Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer, BR J CANC, 81(4), 1999, pp. 609-615
Risultati: 1-7 |